INS and type 2 diabetes mellitus: Traditionally, metformin is thought to primarily act on the liver, and clinical studies in patients with T2D have confirmed that the primary mechanism of action is inhibition of HGP without concomitant increases in plasma insulin concentrations (3, 36, 37, 40-42).